Evoq Technologies Now Showcases Sightgard Platform For Early Detection Of Retinal Diseases At Vision Expo West 2025: Here Is What You Need To Know

Published on September 9, 2025

At Vision Expo West successful Las Vegas from September 18-20, Evoq Technologies is unveiling its innovative SightGard platform, a cutting-edge solution aimed astatine transforming retinal illness detection. The level is group to redefine nan measurement healthcare professionals observe conditions for illustration macular degeneration and diabetic retinopathy, which tin often spell unnoticed until it is excessively precocious for effective intervention. Attendees tin sojourn nan Evoq booth astatine Stand LP12 for a hands-on objection of nan groundbreaking technologies.

A New Era successful Retinal Disease Detection

With advancements successful aesculapian technology, early discovery of retinal diseases is becoming progressively vital. Evoq Technologies, a Nevada-based company, has developed a comprehensive suite of diagnostic tools designed to assistance eye attraction professionals successful identifying retinal issues astatine an early stage. The platform’s cutting-edge solutions harvester simple hardware pinch intuitive app-driven workflows, making precocious oculus diagnostics much accessible and efficient.

Evoq’s toolsystem comprises of 3 pioneering technologies: Twilight, SmartERG, and Gleam FST. These instruments are tailored to amended nan precision and productivity of retinal examinations, starring to much favorable results for patients.

Twilight: Early Warning for Retinal Disease

Among nan contributors to Evoq’s SightGard Platform, Twilight stands retired arsenic a Rapid Dark Adaptation Test. Evoq intends to grow nan capabilities of nan Twilight Tool by allowing it to usability arsenic a afloat automated diagnostic platform. Diagnosing retinal conditions that spell undetected by imaging has ever been a shortcoming of optical coherence tomography (OCT) aliases scanning laser ophthalmoscopes. Twilight greatly expands nan investigative horizons of retinal exams.

SmartERG: Smartphone-Based Retinal Function Analysis

Another important summation to nan SightGard level is SmartERG, a smartphone-based solution that simplifies nan process of retinal usability testing. Electroretinography (ERG) and visual evoked imaginable (VEP) tests person traditionally been analyzable and inaccessible for galore clinics. Evoq’s SmartERG, however, provides an easy-to-use and affordable alternative, allowing much eye attraction professionals to connection broad tests and person data-driven insights connected their patients’ retinal health.

Gleam FST: Revolutionising Inherited Retinal Disease Detection

The gleam FST is simply a portable instrumentality invented by Evoq Technologies which functions arsenic a diagnostic instrumentality for nan early discovery of retinal inherited disease. Early discovery is important for curen effectiveness and proactive management. Eye professionals will now beryllium capable to intervene earlier which tin thief prevention imagination and amended nan lives of galore patients. This instrumentality immunodeficiency Evoq successful enabling imagination attraction professionals to supply test solutions for nan uncommon retinal disorders that was antecedently not feasible.

The Future of Vision Protection

The SightGard platform is overmuch much than conscionable a postulation of diagnostic tools—it’s a vision protection system. Evoq Technologies is committed to creating solutions that not only diagnose but besides generate AI-ready data, ensuring some doctors and patients person nan devices they request to protect imagination for nan future. Through these advancements, Evoq is helping eye attraction professionals observe diseases earlier, intervene sooner, and improve diligent outcomes.

The institution is proud of its groundbreaking approach, which provides valuable information successful an easy-to-understand format for some clinicians and patients. This patient-centric approach is successful statement pinch nan company’s ngo to amended nan standard of care successful ophthalmology and eye health.

Evoq Technologies astatine Vision Expo West 2025: What to Expect

During nan Vision Expo West 2025, sessions slated for SightGard and its accompanying diagnostic devices will see a elaborate position and explanation of nan features connected offer. Attendees willing successful trying their hands astatine nan Twilight acheronian adjustment exam will person nan opportunity to do truthful astatine nan booth stationed astatine Stand LP12 during nan scheduled unrecorded sessions. Evoq Technologies will supply practitioners pinch nan chance to talk nan worth of implementing these devices for enhanced diligent care.

Why This Matters to nan Future of Eye Care

With macular degeneration and diabetic retinopathy affecting millions of group worldwide, early discovery is important successful reducing nan risks of imperishable imagination loss. Evoq Technologies is starring nan measurement successful providing nan latest tools to make these conditions detectable before irreversible harm occurs.

No 1 tin contradict really impactful nan SightGard level will beryllium successful nan early for detecting retinal diseases. Evoq is changing nan paradigm successful oculus attraction by blending technology, data, and simplicity. These devices will not only beryllium economically viable, but their incorporation into nan regular routines of healthcare practitioners will person a world and meaningful effect.